@article{3b45fd85a0444106916afee65bb11887,
title = "The authors reply",
author = "Wu, {Tianshi David} and Chinedu Ejike and Wise, {Robert A.} and McCormack, {Meredith C.} and Brigham, {Emily P.}",
note = "Funding Information: R.A.W. reports receiving fees from GlaxoSmithKline for serving on the SUMMIT clinical endpoint committee during the conduct of the study, as well as institutional grant support and personal consulting fees from GlaxoSmithKline, grants from Sanofi-Aventis, grants and personal fees from AstraZeneca/Medimmune/Pearl, grants and personal fees from Boehringer Ingelheim, and personal fees from Contrafect, Pulmonx, Roche, Spiration, Sunovion, Merck, Circassia, Pneuma, Verona, Bonti, Denali, Aradigm, Mylan, Theravance, Propelloer Health, and AbbVie. The other authors report no potential conflicts of interest.",
year = "2020",
doi = "10.1093/AJE/KWZ245",
language = "English (US)",
volume = "189",
pages = "482",
journal = "American journal of epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "5",
}